"10.1371_journal.pone.0028842","plos one","2011-12-20T00:00:00Z","Béatrice Cambien; Peggy Richard-Fiardo; Babou F Karimdjee; Violette Martini; Bernard Ferrua; Bruno Pitard; Heidy Schmid-Antomarchi; Annie Schmid-Alliana","Université de Nice Sophia Antipolis, UFR Médecine, Nice, France; INSERM UMR 576, Nice, France; Clinique St Jean, Cagnes sur mer, France; INSERM U895, Nice, France; INSERM U915, Nantes, France; In-Cell-Art, Nantes, France","Conceived and designed the experiments: BC. Performed the experiments: BC PR-F BFK VM BF. Analyzed the data: BC BP. Contributed reagents/materials/analysis tools: BP HS-A A-SA. Wrote the paper: BC.","Bruno Pitard owns stock in In-Cell-Art Co., which develops 704 for vaccine applications. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","12","Béatrice Cambien","BC",8,TRUE,1,5,2,1,TRUE,TRUE,FALSE,0,NA,FALSE
